Raymond Huggenberger - 15 Sep 2021 Form 4 Insider Report for Inogen Inc (INGN)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
17 Sep 2021, 16:53:12 UTC
Prior SEC filing
18 Aug 2021
Next SEC filing
11 May 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Alison Bauerlein, as Attorney-in-Fact

Key filing fact

Raymond Huggenberger filed Form 4 for Inogen Inc (INGN) on 17 Sep 2021.

Key facts

  • This page summarizes Raymond Huggenberger's Form 4 filing for Inogen Inc (INGN).
  • 3 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 17 Sep 2021, 16:53.

Change

  • Previous filing in this sequence was filed on 18 Aug 2021.
  • Current net transaction value: -$41,840.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

INGN transaction

Common Stock

Options Exercise

Transaction value
$154,160
Shares
+4,000
Change %
+23%
Price
$38.54
Shares after
21,583
Date
15 Sep 2021
Ownership
Direct
INGN transaction

Common Stock

Sale

Transaction value
$196,000
Shares
-4,000
Change %
-19%
Price
$49.00
Shares after
17,583
Date
15 Sep 2021
Ownership
Direct
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

INGN transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value
$0
Shares
-4,000
Change %
-25%
Price
$0.000000
Shares after
11,806
Date
15 Sep 2021
Ownership
Direct
Underlying class
Common Stock
Underlying amount
4,000
Exercise price
$38.54
Footnotes
F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2021.

Footnote F2

Subject to the reporting person's continuing service, twenty-five percent (25%) of the shares subject to the option shall vest and become exercisable on the one year anniversary of the vesting commencement date, and thereafter, one forty-eighth (1/48th) of the total shares subject to the option shall vest each month on the same day as the vesting commencement date. The vesting commencement date for this option was May 1, 2015.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .